WS MANAGEMENT LLLP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
WS MANAGEMENT LLLP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$842,547
-22.5%
26,6460.0%0.07%
-25.3%
Q2 2023$1,086,624
+9.4%
26,6460.0%0.09%
-13.3%
Q1 2023$993,096
+6.8%
26,6460.0%0.10%
+31.2%
Q4 2022$929,679
-37.6%
26,6460.0%0.08%
-40.7%
Q3 2022$1,491,000
+8.1%
26,6460.0%0.14%
+20.5%
Q2 2022$1,379,000
-28.8%
26,6460.0%0.11%
+17.9%
Q1 2022$1,936,000
-38.6%
26,6460.0%0.10%
-62.2%
Q4 2021$3,151,000
-11.9%
26,6460.0%0.25%
-33.6%
Q3 2021$3,575,000
-17.1%
26,6460.0%0.38%
-11.3%
Q2 2021$4,314,000
+34.5%
26,646
-33.3%
0.43%
+27.9%
Q1 2021$3,208,000
+40.3%
39,969
-4.9%
0.33%
+40.5%
Q4 2020$2,286,000
+173.8%
42,0180.0%0.24%
+163.3%
Q3 2020$835,000
-5.4%
42,0180.0%0.09%
-16.7%
Q2 2020$883,000
+46.7%
42,018
-14.6%
0.11%
+63.6%
Q1 2020$602,000
-20.6%
49,230
-4.8%
0.07%
+1.5%
Q4 2019$758,000
+9.9%
51,7000.0%0.06%
+20.4%
Q3 2019$690,000
-26.6%
51,700
-9.9%
0.05%
-11.5%
Q2 2019$940,000
-14.2%
57,392
-10.6%
0.06%
-7.6%
Q1 2019$1,096,000
+10.3%
64,168
-11.9%
0.07%
+37.5%
Q4 2018$994,000
-71.1%
72,798
-39.3%
0.05%
-57.5%
Q3 2018$3,434,000
+4.6%
120,0000.0%0.11%
+21.5%
Q2 2018$3,283,000120,0000.09%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders